Brief: AN2 Therapeutics Enters Open Market Sale Agreement With Jefferies
20/04/2026 21:35
April 20 (Reuters) - AN2 Therapeutics Inc ANTX.O: AN2 THERAPEUTICS INC - ENTERS OPEN MARKET SALE AGREEMENT WITH JEFFERIES LLC DATED APRIL 9, 2026 - SEC FILING AN2 THERAPEUTICS INC - MAY OFFER AND SELL COMMON STOCK UP TO $80 MILLION THROUGH JEFFERIES - SEC FILING Source text: [ID:n0001193125-26-164095] Further company coverage: ANTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AN2 Therapeutics
See all newsBrief: AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(C)(4)
Brief: An2 Therapeutics Announces Extension Of Funding For Tuberculosis Research Collaboration With Gsk
AN2 Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
AN2 Therapeutics Q2 net loss widens on higher R&D costs
AN2 Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview